Like previous findings, COVID-19 plasma treatment on primary endothelial cells induced soluble EG shedding, however, differences in syndecan-1 shedding but not glypican-1 disruption was more prominent between COVID-19 severity14,15. This evidence concerns the gene GPC1 and COVID-19.